Daratumumab, a CD38 mab, for the treatment of relapsed/refractory multiple myeloma patients: Preliminary efficacy data from a multicenter phase I/II study

Henk Lokhorst, Torben Plesner, Peter Gimsing, Hareth Nahi, Monique Minnema, Ulrik Niels Lassen, Jakub Krejcik, Jacob Laubach, Steen Lisby, Linda Basse, Paul Richardson

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdatomaj 2013
StatusUdgivet - maj 2013
BegivenhedAnnual Meeting of the American Society of Clinical Oncology - Chicago, USA
Varighed: 31. maj 20134. jun. 2013

Konference

KonferenceAnnual Meeting of the American Society of Clinical Oncology
LandUSA
ByChicago
Periode31/05/201304/06/2013

Citationsformater